Olink Proteomics AB

Uppsala län Part of Thermo Fisher Scientific Inc.

UEI
SC7KUWJQ7MY5
CAGE
AM79N
Primary NAICS
541380 Testing Laboratories and Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
Salagatan 16F, 753 30 Uppsala, Sweden
Website
olink.com
Founded
2004
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$6,290
FY2025 -$11,219
FY2024 -$623
FY2023 $289,576

Contract awards

Award Agency Obligated Awarded
Biological and reagent material - direct use 75N91024K00004 National Cancer Institute (NIH) $10,079
Profiling of individuals of african descent with metabolic disorders 75N92023P00252 National Heart Lung and Blood Institute (NIH) $179,738
Task order for olink target-96 immuno-oncology analysis service in support of NIH/NCI/CCR/center for immuno-oncology 75N91023F00001 National Cancer Institute (NIH) $50,688
The NCI proposes to test 440 samples using the olink target 96 inflammation panel 75N91023F00002 National Cancer Institute (NIH) $63,492
Nichd services: lab services 75N94022P00681 National Institute of Child Health and Human Development (NIH) $69,388

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
Pelago Bioscience AB UEI PXCTD3HCRKN4 Stockholms län 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Mabtech Inc. UEI DS66FGV4VAW8 Cincinnati, OH 459999 All Other Miscellaneous Retailers
Quanterix Corporation UEI FMFEHF5ACEV2 Billerica, MA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Bio-Techne Corporation UEI RDJKATCM39L5 — 325414 Biological Product (except Diagnostic) Manufacturing
Abcam Inc. UEI CCKFL5P2M9X3 Waltham, MA 325414 Biological Product (except Diagnostic) Manufacturing

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Olink Proteomics AB is a foreign-owned, for-profit corporate entity based in Sweden that specializes in proprietary multiplex protein biomarker analysis technologies and services. The company provides various reagent kits, array chips, and multiplex protein testing platforms like Olink Explore and Olink Target to federal agencies for biomedical research applications across disease areas.

Through numerous firm fixed price purchase orders, delivery orders, and indefinite delivery contracts, Olink Proteomics AB has supplied federal agencies like the National Institutes of Health (NIH), Food and Drug Administration (FDA), and Department of Veterans Affairs (VA) with proteomics analysis services and products. Specific services include immuno-oncology, inflammation, metabolism, and pediatric oncology protein biomarker panels to support cancer, cardiovascular disease, infectious disease, and COVID-19 research efforts. Olink has evaluated circulating biomarkers, conducted large-scale profiling of plasma/blood samples across thousands of proteins, and delivered multiplex assay kits enabling high-throughput protein quantification for agencies. Most contracts were awarded through simplified acquisitions without set-asides, including several sole-source awards citing Olink's unique capabilities. As a subcontractor, Olink has also provided sample preparation services to prime contractors like Johns Hopkins University.

Olink Proteomics AB holds a single award indefinite delivery contract with NIH's National Cancer Institute, valued at $699,900, to provide protein biomarker analysis services supporting cancer epidemiology studies. To date, task orders issued total around $700,000 for immuno-oncology, inflammation, and pediatric oncology analysis using Olink's proprietary multiplex platforms, performed in Massachusetts, Maryland, and Washington D.C. The original solicitation sought a sole-source award to Olink to ensure data comparability across the agency's research efforts evaluating circulating biomarkers in cancer patients. Services include aliquoting samples and testing for protein biomarkers to advance the Division of Cancer Epidemiology and Genetics' epidemiological and genetic cancer research mission.

Quick answers

Is Olink Proteomics AB registered in SAM.gov?

Yes. Olink Proteomics AB's SAM.gov registration is active through January 7, 2027.

How much has Olink Proteomics AB received in federal contracts?

Federal contracts obligated $271,444 to Olink Proteomics AB in fiscal years 2023 through 2027.

What is Olink Proteomics AB's most recent federal award?

Olink Proteomics AB's most recent federal contract award is Biological and reagent material - direct use (75N91024K00004), from National Cancer Institute (NIH), on November 29, 2023.

On GovTribe

See Olink Proteomics AB's full federal record

  • Federal contract awards
  • IDV awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login